English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Feb 22, 2026

Early study finds mixed allergy risks for cultured beef compared to traditional steak
+ Pharmaceuticals
Patient Daily | Feb 22, 2026

Undiagnosed diabetes and kidney issues contribute to higher heart risks
+ Pharmaceuticals
Patient Daily | Feb 22, 2026

Study reveals role of lingering cytokines in sustaining immune cell memory
+ Pharmaceuticals
Patient Daily | Feb 22, 2026

Ionis expands commercial presence after strong initial launch of Tryngolza
+ Pharmaceuticals
Patient Daily | Feb 22, 2026

Exercise and protein drinks linked to improved function for people with dementia
+ Pharmaceuticals
Patient Daily | Feb 22, 2026

Patent strategies delay entry of generic drugs and keep prices high
+ Pharmaceuticals
Patient Daily | Feb 22, 2026

Study finds parental concern better than digital tools for spotting severe childhood illnesses
+ Pharmaceuticals
Patient Daily | Feb 22, 2026

Korsana launches with $150M series A to develop new Alzheimer’s antibody

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes